Zymera Licenses Life Technologies' Qdot Technology

May 14, 2009

NEW YORK (GenomeWeb News) – Life Technologies said today that Zymera has licensed its quantum dot intellectual property portfolio.

Zymera plans to use the Qdot nanocrystals to create self-illuminating quantum dot products that will be used in in vivo imaging, biomarker discovery, and in biosensing applications. Zymera's self-illumination technology uses bioluminescence resonance energy transfer, to transfer light from bioluminescent proteins, such as luciferase, onto quantum dots.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Gene Therapy for SCID-X1

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

Same Scam, New Tech

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

To Guide the Genealogy Search

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

This Week in Nature

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Menu